RARE : Ultragenyx Pharmaceutical stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-12-04 |
|---|---|---|---|---|
| 2025 | $47.37 | $45.25 | $51.6 | 0.56% |
| 2026 | $46.46 | $30.14 | $57.16 | -1.38% |
| 2027 | $41.71 | $37.97 | $43.59 | -11.46% |
| 2028 | $47.02 | $38.88 | $50.68 | -0.19% |
| 2029 | $33.49 | $27.35 | $36.9 | -28.91% |
| 2030 | $36.26 | $33.5 | $38.9 | -23.03% |
| 2031 | $37.23 | $24.61 | $41.67 | -20.98% |
| 2032 | $27.25 | $25.14 | $28.74 | -42.17% |
| 2033 | $31.36 | $28.26 | $33.76 | -33.43% |
| 2034 | $35.66 | $32.86 | $37.5 | -24.3% |
The 22 Wall Street analysts offering Ultragenyx Pharmaceutical stock forecast in the last 6 months have average price target of
$95.14 with a high forecast of $121.0 and a low forecast of $45.0.
The average Ultragenyx Pharmaceutical stock forecast represents a 101.95%
increase from the last price of $47.1100006103516.
For Ultragenyx Pharmaceutical stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Ultragenyx Pharmaceutical stock
forecast of $47.37, a high forecast of $51.6, and a low forecast of $45.25.
The average Ultragenyx Pharmaceutical stock forecast 2025 represents a 0.56%
increase from the last price of $47.1100006103516.
For Ultragenyx Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Ultragenyx Pharmaceutical stock
forecast of $46.46, a high forecast of $57.16, and a low forecast of $30.14.
The average Ultragenyx Pharmaceutical stock forecast 2026 represents a -1.38%
decrease from the last price of $47.1100006103516.
For Ultragenyx Pharmaceutical stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Ultragenyx Pharmaceutical stock
forecast of $47.02, a high forecast of $50.68, and a low forecast of $38.88.
The average Ultragenyx Pharmaceutical stock forecast 2028 represents a -0.19%
decrease from the last price of $47.1100006103516.
For Ultragenyx Pharmaceutical stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Ultragenyx Pharmaceutical stock
forecast of $36.26, a high forecast of $38.9, and a low forecast of $33.5.
The average Ultragenyx Pharmaceutical stock forecast 2030 represents a -23.03%
decrease from the last price of $47.1100006103516.
For Ultragenyx Pharmaceutical stock forecast 2031, 12 predictions are offered for each month of 2031 with average Ultragenyx Pharmaceutical stock
forecast of $37.23, a high forecast of $41.67, and a low forecast of $24.61.
The average Ultragenyx Pharmaceutical stock forecast 2031 represents a -20.98%
decrease from the last price of $47.1100006103516.
Please, see more forecasts below.
RARE : Ultragenyx Pharmaceutical stock forecast by Wall Street Analysts
The average Ultragenyx Pharmaceutical stock forecast from last 6 month is $95.14, and this show a 2.91% increase in average from the prior price target of the each prediction. Also, this average forecast of $95.14 represents a 11.25% increase from the past average forecast of $85.52, 6 months ago from 23 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-11-21 | JP Morgan | $105.0000 | $102.0000 | Overweight |
| 2024-11-12 | Canaccord Genuity | $121.0000 | $121.0000 | Buy |
| 2024-11-06 | HC Wainwright & Co. | $82.00 | $95 | Buy |
| 2024-11-06 | Cantor Fitzgerald | $116.00 | $116.00 | Overweight |
| 2024-11-06 | RBC Capital | $77.00 | $77.00 | Outperform |
| 2024-11-06 | Canaccord Genuity | $109.0000 | $121.0000 | Buy |
| 2024-10-22 | Cantor Fitzgerald | $116.00 | $116.00 | Overweight |
| 2024-10-21 | TD Cowen | $61.00 | $73.0000 | Buy |
| 2024-10-01 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-09-26 | RBC Capital | $77.00 | $77.00 | Outperform |
| 2024-09-20 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-09-16 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-08-05 | Barclays | $83.0000 | $81.0000 | Overweight |
| 2024-08-02 | Wedbush | $43.0000 | $46 | Neutral |
| 2024-08-02 | Cantor Fitzgerald | $115.00 | $116 | Overweight |
| 2024-08-02 | Goldman Sachs | $67.00 | $76 | Buy |
| 2024-08-02 | Wells Fargo | $72.00 | $75.0000 | Overweight |
| 2024-07-23 | Canaccord Genuity | $111.00 | $111.0000 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $115.00 | $115.0000 | Overweight |
| 2024-07-18 | Wedbush | $45.0000 | $45 | Neutral |
| 2024-06-12 | Cantor Fitzgerald | $115.00 | $115.0000 | Overweight |
| 2024-06-06 | Goldman Sachs | $56.0000 | $67 | Buy |
| 2024-05-31 | Baird | $68.00 | $72 | Outperform |
| 2024-05-31 | Stifel | $124.0000 | $127.0000 | Buy |
| 2024-05-31 | Cantor Fitzgerald | $107.00 | $115 | Overweight |
| 2024-05-31 | Canaccord Genuity | $109.00 | $111.0000 | Buy |
| 2024-05-31 | B of A Securities | $83.0000 | $76 | Buy |
| 2024-05-31 | Wedbush | $47.00 | $48.0000 | Neutral |
| 2024-05-06 | Canaccord Genuity | $111.00 | $109.0000 | Buy |
| 2024-05-03 | Wedbush | $48.00 | $47.0000 | Neutral |
| 2024-05-03 | Cantor Fitzgerald | $107.00 | Overweight | |
| 2024-04-24 | TD Cowen | $59.0000 | $61.0000 | Buy |
| 2024-04-22 | RBC Capital | $77.0000 | Outperform | |
| 2024-04-17 | Wedbush | $48.0000 | Neutral | |
| 2024-04-16 | Wedbush | $48 | Neutral | |
| 2024-04-05 | Cantor Fitzgerald | $107.0000 | Overweight | |
| 2024-03-18 | JP Morgan | $88.00 | $92.0000 | Overweight |
| 2024-02-27 | Cantor Fitzgerald | $107.0000 | Overweight | |
| 2024-02-27 | JP Morgan | $84.0000 | $88 | Overweight |
| 2024-02-21 | Canaccord Genuity | $110.0000 | $111.0000 | Buy |
| 2024-02-16 | Wedbush | $47.0000 | $48.0000 | Neutral |
| 2024-02-15 | Cantor Fitzgerald | $114.0000 | Overweight | |
| 2024-01-30 | Baird | $57.00 | $68.0000 | Outperform |
| 2024-01-19 | Cantor Fitzgerald | $114.0000 | Overweight | |
| 2023-12-08 | Wells Fargo | $72.0000 | Overweight |
Ultragenyx Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-12-06 | $47.83 | 1.53% |
| 2024-12-09 | $47.69 | -0.29% |
| 2024-12-10 | $48.55 | 1.81% |
| 2024-12-11 | $48.55 | -0.00% |
| 2024-12-12 | $47.21 | -2.76% |
RARE : Long term Ultragenyx Pharmaceutical stock forecast for 2024 - 2025 - 2030
Forecast for 2025 Jan. is $46.33 , for 2025 Dec. is $51.60 , for 2028 Dec. is $38.88 , for 2029 Dec. is $34.04 , for 2033 Dec. is $33.76 , and for 2034 Dec. is $32.86.
RARE : Ultragenyx Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $46.33 | -1.67% |
| 2025 Feb. | $45.43 | -1.94% |
| 2025 Mar. | $45.25 | -0.39% |
| 2025 Apr. | $45.57 | 0.70% |
| 2025 May. | $45.97 | 0.89% |
| 2025 Jun. | $46.51 | 1.16% |
| 2025 Jul. | $46.91 | 0.87% |
| 2025 Aug. | $47.54 | 1.33% |
| 2025 Sep. | $48.16 | 1.32% |
| 2025 Oct. | $49.02 | 1.78% |
| 2025 Nov. | $50.19 | 2.38% |
| 2025 Dec. | $51.60 | 2.82% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $53.35 | 3.39% |
| 2026 Feb. | $55.20 | 3.48% |
| 2026 Mar. | $56.61 | 2.55% |
| 2026 Apr. | $57.16 | 0.96% |
| 2026 May. | $56.49 | -1.16% |
| 2026 Jun. | $54.28 | -3.91% |
| 2026 Jul. | $50.26 | -7.42% |
| 2026 Aug. | $43.80 | -12.84% |
| 2026 Sep. | $35.94 | -17.95% |
| 2026 Oct. | $30.34 | -15.58% |
| 2026 Nov. | $30.14 | -0.66% |
| 2026 Dec. | $33.92 | 12.54% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $37.97 | 11.95% |
| 2027 Feb. | $40.67 | 7.10% |
| 2027 Mar. | $42.10 | 3.50% |
| 2027 Apr. | $42.62 | 1.25% |
| 2027 May. | $42.57 | -0.11% |
| 2027 Jun. | $42.25 | -0.76% |
| 2027 Jul. | $41.85 | -0.95% |
| 2027 Aug. | $41.52 | -0.78% |
| 2027 Sep. | $41.37 | -0.37% |
| 2027 Oct. | $41.59 | 0.53% |
| 2027 Nov. | $42.41 | 1.97% |
| 2027 Dec. | $43.59 | 2.78% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $44.70 | 2.56% |
| 2028 Feb. | $45.76 | 2.36% |
| 2028 Mar. | $46.88 | 2.45% |
| 2028 Apr. | $48.11 | 2.61% |
| 2028 May. | $49.34 | 2.56% |
| 2028 Jun. | $50.32 | 1.99% |
| 2028 Jul. | $50.68 | 0.71% |
| 2028 Aug. | $50.31 | -0.73% |
| 2028 Sep. | $49.04 | -2.52% |
| 2028 Oct. | $46.77 | -4.64% |
| 2028 Nov. | $43.43 | -7.14% |
| 2028 Dec. | $38.88 | -10.48% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $33.09 | -14.88% |
| 2029 Feb. | $28.21 | -14.75% |
| 2029 Mar. | $27.35 | -3.04% |
| 2029 Apr. | $29.75 | 8.77% |
| 2029 May. | $33.18 | 11.52% |
| 2029 Jun. | $35.73 | 7.70% |
| 2029 Jul. | $36.82 | 3.05% |
| 2029 Aug. | $36.90 | 0.21% |
| 2029 Sep. | $36.42 | -1.29% |
| 2029 Oct. | $35.61 | -2.24% |
| 2029 Nov. | $34.73 | -2.45% |
| 2029 Dec. | $34.04 | -1.98% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $33.61 | -1.27% |
| 2030 Feb. | $33.50 | -0.34% |
| 2030 Mar. | $33.88 | 1.14% |
| 2030 Apr. | $34.69 | 2.40% |
| 2030 May. | $35.60 | 2.60% |
| 2030 Jun. | $36.36 | 2.15% |
| 2030 Jul. | $36.96 | 1.66% |
| 2030 Aug. | $37.42 | 1.23% |
| 2030 Sep. | $37.75 | 0.89% |
| 2030 Oct. | $38.06 | 0.81% |
| 2030 Nov. | $38.42 | 0.96% |
| 2030 Dec. | $38.90 | 1.26% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $39.53 | 1.60% |
| 2031 Feb. | $40.27 | 1.88% |
| 2031 Mar. | $41.03 | 1.90% |
| 2031 Apr. | $41.56 | 1.29% |
| 2031 May. | $41.67 | 0.24% |
| 2031 Jun. | $41.49 | -0.42% |
| 2031 Jul. | $40.94 | -1.31% |
| 2031 Aug. | $39.47 | -3.60% |
| 2031 Sep. | $36.48 | -7.56% |
| 2031 Oct. | $32.16 | -11.86% |
| 2031 Nov. | $27.49 | -14.51% |
| 2031 Dec. | $24.61 | -10.48% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $25.14 | 2.14% |
| 2032 Feb. | $27.36 | 8.85% |
| 2032 Mar. | $28.74 | 5.04% |
| 2032 Apr. | $28.63 | -0.40% |
| 2032 May. | $27.94 | -2.41% |
| 2032 Jun. | $27.30 | -2.27% |
| 2032 Jul. | $26.89 | -1.49% |
| 2032 Aug. | $26.71 | -0.67% |
| 2032 Sep. | $26.71 | -0.00% |
| 2032 Oct. | $26.83 | 0.44% |
| 2032 Nov. | $27.10 | 1.01% |
| 2032 Dec. | $27.59 | 1.81% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $28.26 | 2.45% |
| 2033 Feb. | $29.01 | 2.64% |
| 2033 Mar. | $29.71 | 2.40% |
| 2033 Apr. | $30.30 | 2.01% |
| 2033 May. | $30.82 | 1.72% |
| 2033 Jun. | $31.30 | 1.56% |
| 2033 Jul. | $31.77 | 1.50% |
| 2033 Aug. | $32.24 | 1.47% |
| 2033 Sep. | $32.68 | 1.36% |
| 2033 Oct. | $33.06 | 1.17% |
| 2033 Nov. | $33.40 | 1.02% |
| 2033 Dec. | $33.76 | 1.07% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $34.22 | 1.37% |
| 2034 Feb. | $34.72 | 1.48% |
| 2034 Mar. | $35.15 | 1.21% |
| 2034 Apr. | $35.67 | 1.49% |
| 2034 May. | $36.41 | 2.08% |
| 2034 Jun. | $37.15 | 2.02% |
| 2034 Jul. | $37.50 | 0.96% |
| 2034 Aug. | $37.35 | -0.42% |
| 2034 Sep. | $36.75 | -1.59% |
| 2034 Oct. | $35.77 | -2.69% |
| 2034 Nov. | $34.43 | -3.74% |
| 2034 Dec. | $32.86 | -4.55% |
Frequently Asked Questions about Ultragenyx Pharmaceutical stock forecast
Is Ultragenyx Pharmaceutical a good long term stock?
From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2025 Jan. is $46.3253560954606 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2025 Dec. is $51.6017957114239 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2028 Dec. is $38.8788466343756 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2029 Dec. is $34.0446507063261 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2033 Dec. is $33.7567625561577 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2034 Dec. is $32.8607171943123
Is Ultragenyx Pharmaceutical stock overvalued?
Ultragenyx Pharmaceutical (RARE) stock is expected to go UP . Therefore, AIPickup would say that Ultragenyx Pharmaceutical (RARE) stock is NOT overvalued.
Will Ultragenyx Pharmaceutical stock price go up?
Yes. The Ultragenyx Pharmaceutical stock price forecast for 2025 Dec. is $51.6017957114239
Is Ultragenyx Pharmaceutical stock a good buy now?
Since closing price on 2024-12-04 is $47.1100006103516 and forecast for 2025 Dec. is $51.60, Ultragenyx Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for Ultragenyx Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| RARE stock price for 2024-11-14 | $47.64 | $48.41 | $47.59 | $48.60 |
| RARE stock price for 2024-11-15 | $44.75 | $47.36 | $44.53 | $48.11 |
| RARE stock price for 2024-11-18 | $43.78 | $44.50 | $43.04 | $44.92 |
| RARE stock price for 2024-11-19 | $45.13 | $43.90 | $43.38 | $45.15 |
| RARE stock price for 2024-11-20 | $46.40 | $44.91 | $44.90 | $46.98 |
| RARE stock price for 2024-11-21 | $46.02 | $46.02 | $45.90 | $47.14 |
| RARE stock price for 2024-11-22 | $47.24 | $46.07 | $45.47 | $47.47 |
| RARE stock price for 2024-11-25 | $47.12 | $47.59 | $47.00 | $48.62 |
| RARE stock price for 2024-11-26 | $47.36 | $47.18 | $46.60 | $47.53 |
| RARE stock price for 2024-11-27 | $48.13 | $47.69 | $46.96 | $48.24 |
| RARE stock price for 2024-11-29 | $47.63 | $48.12 | $47.37 | $48.23 |
| RARE stock price for 2024-12-02 | $47.60 | $47.69 | $47.34 | $48.13 |
| RARE stock price for 2024-12-03 | $46.67 | $47.38 | $46.27 | $47.67 |
| RARE stock price for 2024-12-04 | $47.11 | $46.50 | $46.40 | $48.22 |